Skip to content
healthcare.dev
Get a free key

Xeomin

NDC 46783-165, incobotulinumtoxinA, injection, powder, lyophilized, for solution, from Merz North America, Inc..

Product NDC
46783-165
Status
Listed
Labeler
Merz North America, Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAMUSCULAR
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125360
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/46783-165 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BOTULINUM TOXIN TYPE A50 [USP'U]/1

Pharmacologic classes

Acetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]; Neuromuscular Blockade [PE]; Neuromuscular Blocker [EPC]

Package NDCNDC-11Package
46783-165-01467830165011 VIAL, SINGLE-USE in 1 CARTON (46783-165-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3f35d6e0-3450-4abc-a0da-cc7b277e7c6e

Use it

Look up 46783-165 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/46783-165 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 46783-165. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.